Dexamethasone Tolerability in the Treatment of Acute Asthma in Children
NCT ID: NCT00973687
Last Updated: 2015-08-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
430 participants
INTERVENTIONAL
2004-09-30
2006-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Single Dose Oral Dexamethasone Versus Multi-dose Prednisolone in the Treatment of Acute Exacerbations of Asthma in Children
NCT03698630
Dexamethasone Versus Prednisone for Asthma Treatment in the Pediatric Inpatient Population; a Feasibility Study
NCT03133897
Comparison of Oral Dexamethasone Doses in Asthma Exacerbation
NCT00942201
Steroids In The Management Of Acute Asthma Exacerbations In Children, Which Form Is More Suitable?
NCT03204760
Steroids in Children Hospitalized With Asthma
NCT02780479
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
10 mg/mL Unsweetened Formulation
no prior vomiting
Dexamethasone
1 mg/mL Ora Sweet Formulation
no prior vomiting
Ora Sweet
A pharmaceutical suspending vehicle and flavouring agent added to the dexamethasone. All arms received the same amount of dexamethasone based on the child's weight, only in different volumes.
Dexamethasone
10 mg/mL Unsweetened with prior vomiting
with prior vomiting
Dexamethasone
1 mg/mL Ora Sweet with prior vomiting
with prior vomiting
Ora Sweet
A pharmaceutical suspending vehicle and flavouring agent added to the dexamethasone. All arms received the same amount of dexamethasone based on the child's weight, only in different volumes.
Dexamethasone
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ora Sweet
A pharmaceutical suspending vehicle and flavouring agent added to the dexamethasone. All arms received the same amount of dexamethasone based on the child's weight, only in different volumes.
Dexamethasone
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* requiring oral systemic corticosteroids for management
Exclusion Criteria
* history of Nissen fundoplication surgery
* needed immediate airway intervention
* require oral medications to be given via a G or J tube
* if patient care would be compromised
* enrolled in the study on a previous visit.
2 Years
14 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
IWK Foundation
UNKNOWN
IWK Health Centre
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
IWK Health Centre
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lyn K Sonnenberg, MD
Role: PRINCIPAL_INVESTIGATOR
IWK Health Centre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IWK Health Centre
Halifax, Nova Scotia, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2967
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.